The EC has approved an update to the Victoza® (liraglutide) EU label that expands the indication to reflect both improving...
Read morePersonalMed, LLC, has entered into a collaborative agreement with AmerisourceBergen’s pharmacy services administrative organization (PSAO), Elevate Provider Network, to introduce...
Read moreNuMedii, Inc announced the formation of a strategic partnership with Three Lakes Partners, LLC, to discover and advance new treatments for...
Read moreMedidata the leading global provider of cloud-based technology and data analytics for clinical research, is pleased to announce that its...
Read moreAscendis Pharma A/S ,biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases...
Read moreIntralytix, Inc. announced that the Company is partnering with BioPhage Therapeutics Limited to develop and commercialize topical bacteriophage treatments of...
Read moreNeurim Pharmaceuticals and Exeltis announced a license agreement in which Exeltis will obtain exclusive marketing rights for Neurim’s new Rx...
Read moreTo help address the challenges surrounding supply chain management for cell and gene therapy around the globe, Thermo Fisher Scientific,...
Read moreQR Pharma, Inc., a privately held phase 2 biopharmaceutical company developing novel therapies for the treatment of Alzheimer’s (AD), Parkinson’s...
Read moreJazz Pharm announced that the first patient has been enrolled in a Phase 2 clinical study evaluating JZP-110 , a...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.
